HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
B Falini Selected Research
B Falini Research Topics
Disease
13
Neoplasms (Cancer)
02/2015 - 01/2000
10
Lymphoma (Lymphomas)
06/2015 - 02/2000
7
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2015 - 01/2000
6
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2015 - 08/2005
2
T-Cell Lymphoma (Lymphoma, T Cell)
11/2009 - 11/2008
2
Myeloid Sarcoma (Chloroma)
10/2009 - 07/2007
2
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2008 - 01/2002
2
Lymphadenitis (Adenitis)
05/2006 - 09/2001
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2002 - 01/2002
2
Hodgkin Disease (Hodgkin's Disease)
01/2002 - 01/2001
2
B-Cell Lymphoma (Lymphoma, B Cell)
01/2002 - 02/2001
2
Multiple Myeloma
09/2001 - 07/2001
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2013
1
Lupus Nephritis
10/2013
1
Hairy Cell Leukemia
12/2012
1
Blast Crisis (Blast Phase)
07/2009
1
Chromosome Aberrations (Chromosome Abnormalities)
02/2007
1
Residual Neoplasm
06/2006
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2002
1
Lymphomatoid Papulosis
01/2002
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2002
1
Castleman Disease (Castleman's Disease)
09/2001
1
Lymphadenopathy
09/2001
1
Sinus Histiocytosis (Rosai-Dorfman Disease)
09/2001
1
Melanoma (Melanoma, Malignant)
07/2001
1
Carcinogenesis
07/2001
1
Sclerosis
02/2001
1
Leukemia
11/2000
1
Acute Promyelocytic Leukemia
11/2000
1
Common Variable Immunodeficiency
09/2000
1
Rheumatoid Arthritis
04/2000
Drug/Important Bio-Agent (IBA)
12
Nucleophosmin
IBA
02/2015 - 01/2000
9
Proteins (Proteins, Gene)
FDA Link
10/2005 - 02/2000
7
Anaplastic Lymphoma Kinase
IBA
06/2015 - 01/2000
4
Paraffin
IBA
10/2009 - 11/2000
2
Antibodies
IBA
07/2002 - 09/2001
2
Tyrosine (L-Tyrosine)
FDA Link
01/2002 - 09/2000
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2002 - 08/2000
2
Monoclonal Antibodies
IBA
11/2000 - 06/2000
1
Proteasome Inhibitors
IBA
06/2015
1
Interleukin-17 (Interleukin 17)
IBA
10/2013
1
MicroRNAs (MicroRNA)
IBA
12/2012
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2008
1
Superantigens
IBA
05/2006
1
Bleomycin (Blenoxane)
FDA Link
Generic
09/2002
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2002
1
Etoposide (VP 16)
FDA Link
Generic
09/2002
1
Mitoxantrone (Novantrone)
FDA Link
Generic
09/2002
1
Prednisone (Sone)
FDA Link
Generic
09/2002
1
Vincristine (Oncovin)
FDA Link
Generic
09/2002
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
09/2002
1
S100 Proteins (S 100 Protein)
IBA
07/2002
1
Muramidase (Lysozyme)
IBA
07/2002
1
Antigens
IBA
07/2002
1
Phosphotyrosine
IBA
01/2002
1
Peroxidase (Myeloperoxidase)
IBA
09/2001
1
Epitopes
IBA
09/2001
1
Transcription Factors (Transcription Factor)
IBA
01/2001
1
Immunoglobulins (Immunoglobulin)
IBA
01/2001
1
Retinoic Acid Receptors (Retinoic Acid Receptor)
IBA
11/2000
1
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
IBA
11/2000
1
Pyridinolcarbamate (P23)
IBA
06/2000
1
Cyclin A
IBA
06/2000
1
Phosphoproteins
IBA
02/2000
1
Indicators and Reagents (Reagents)
IBA
01/2000
1
Phosphotransferases (Kinase)
IBA
01/2000
Therapy/Procedure
6
Therapeutics
11/2008 - 04/2000
4
Drug Therapy (Chemotherapy)
12/2002 - 02/2001
1
Orchiectomy (Orchidectomy)
09/2002
1
Immunotherapy
09/2001
1
Radiotherapy
02/2001